SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-23-001312
Filing Date
2023-08-10
Accepted
2023-08-10 08:00:33
Documents
14
Period of Report
2023-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 EDGEWISE THERAPEUTICS, INC. 8-K a53523949.htm   iXBRL 8-K 29941
2 EXHIBIT 99.1 a53523949_ex991.htm EX-99.1 64234
  Complete submission text file 0001157523-23-001312.txt   281107

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ewtx-20230810.xsd EX-101.SCH 4083
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ewtx-20230810_def.xml EX-101.DEF 17549
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ewtx-20230810_lab.xml EX-101.LAB 26909
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ewtx-20230810_pre.xml EX-101.PRE 19749
8 EXTRACTED XBRL INSTANCE DOCUMENT a53523949_htm.xml XML 5651
Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40236 | Film No.: 231157239
SIC: 2834 Pharmaceutical Preparations